Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee R Anderko

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Leukocyte Biology|February 23, 2023
Mapping the interplay between NK cells and HIV: therapeutic implicationsRenee R Anderko, Robbie B Mailliard
Cell Reports. Medicine|November 17, 2022
Identifying inflammatory phenotypes to target mechanism-specific treatments in sepsisHernando Gómez, Renee R Anderko, Joseph A Carcillo
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2020
IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγ<sup>-</sup> NK CellsRenee R Anderko, Charles R Rinaldo, Robbie B Mailliard
Journal of Leukocyte Biology|October 29, 2024
Combination therapy with immune agonists and senescence-inducing agents delivers promise for immunotherapeutic success in pancreatic cancerRenee R Anderko, Amer H Zureikat, Tullia C Bruno
Surgical Oncology Clinics of North America|March 28, 2026
B-cell-directed Immunotherapy for Solid TumorsRenee R Anderko, Adam Tcharni, Amer H Zureikat, et al.
Intensive Care Medicine Experimental|February 22, 2022
Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activationRenee R Anderko, Hernando Gómez, Scott W Canna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell populationRenee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Frontiers in Immunology|June 22, 2026
Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cellsE Grace Bothwell, Allison E DePuyt, Colleen R Zaccard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2024
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral TherapyRenee R Anderko, Allison E DePuyt, Rhianna Bronson, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Leukocyte Biology|February 23, 2023
Mapping the interplay between NK cells and HIV: therapeutic implicationsRenee R Anderko, Robbie B Mailliard
Cell Reports. Medicine|November 17, 2022
Identifying inflammatory phenotypes to target mechanism-specific treatments in sepsisHernando Gómez, Renee R Anderko, Joseph A Carcillo
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2020
IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγ<sup>-</sup> NK CellsRenee R Anderko, Charles R Rinaldo, Robbie B Mailliard
Journal of Leukocyte Biology|October 29, 2024
Combination therapy with immune agonists and senescence-inducing agents delivers promise for immunotherapeutic success in pancreatic cancerRenee R Anderko, Amer H Zureikat, Tullia C Bruno
Surgical Oncology Clinics of North America|March 28, 2026
B-cell-directed Immunotherapy for Solid TumorsRenee R Anderko, Adam Tcharni, Amer H Zureikat, et al.
Intensive Care Medicine Experimental|February 22, 2022
Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activationRenee R Anderko, Hernando Gómez, Scott W Canna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell populationRenee R Anderko, Alexandra E Bowman, Praneel Murthy, et al.
Frontiers in Immunology|June 22, 2026
Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cellsE Grace Bothwell, Allison E DePuyt, Colleen R Zaccard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2024
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral TherapyRenee R Anderko, Allison E DePuyt, Rhianna Bronson, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Pageof 1